Mammalian sterile 20-like kinases in tumor suppression: an emerging pathway

Cancer Res. 2005 Jul 1;65(13):5485-7. doi: 10.1158/0008-5472.CAN-05-1453.

Abstract

Emerging evidence suggests that the proapoptotic kinase mammalian sterile 20-like kinase 2 (MST2) acts in a novel tumor suppression pathway. Recently, we showed that Raf-1 kinase sequesters and inhibits MST2 and that this event is critical for Raf-mediated cell survival. In this review, we summarize Raf control of MST2 and we outline a novel pathway involving the downstream effector proteins Salvador and Warts/Lats that may act to limit the positive effects of Raf-mitogen-activated protein kinase signaling in cancer cells.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Apoptosis / physiology
  • Humans
  • Intracellular Signaling Peptides and Proteins
  • Neoplasms / enzymology*
  • Neoplasms / pathology
  • Protein Serine-Threonine Kinases / metabolism*
  • Proto-Oncogene Proteins c-raf / metabolism
  • Serine-Threonine Kinase 3

Substances

  • Intracellular Signaling Peptides and Proteins
  • Stk4 protein, mouse
  • STK4 protein, human
  • Protein Serine-Threonine Kinases
  • Proto-Oncogene Proteins c-raf
  • STK3 protein, human
  • Serine-Threonine Kinase 3
  • Stk3 protein, mouse